CClinicalTrials.gg
CompletedNCT01254149Updated Sep 1, 2023

IOP Lowering Effects of Topical Anesthetics Used Frequently in the Ophthalmology Clinic

An observational study in Normal Tension Glaucoma, sponsored by University of Nebraska. Completed at 1 site in United States. Open to participants aged 19 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-01.

Sponsored by University of Nebraska · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
43
Ages
19 Years and older
Sex
All
01

Study summary

The primary purpose of this study is to determine whether topical ophthalmic anesthetics lower the intraocular pressure in the eye.

Read the detailed description

Each day almost all patients in an ophthalmology clinic get their intraocular pressure of each eye measured. This measurement is used to make important decisions regarding risk of dilation and also is essential in the management of glaucoma patients, as intraocular pressure (IOP) remains one of the only modifiable factors in glaucoma. The intraocular pressure is also measured in an eye that has undergone an operative procedure where pressures can increase to dangerous levels signaling the need for immediate intervention.

In most ophthalmology clinics the intraocular pressure is measured via Goldmann applanation tonometry, which is considered the standard method of measurement. The Goldmann tonometer is a device that uses an applanation prism to flatten a small portion of the cornea to measure the eye. The pressure within the eye is determined by how much force is needed to flatten the cornea. In order to perform the test the subject receives a topical anesthetic and fluorescein sodium dye on the surface of the eye. The intraocular pressure is all frequently measured in ophthalmology by pneumatonometry and the Tonopen. These two additional methods of contact tonometry measure the amount of force needed to displace the cornea and then calculate the intraocular pressure1. Both require instillation of topical anesthetic eye drops prior to measuring the pressure, cut these latter two methods require no dye. The principal anesthetics used in the United States are proparacaine or benoxinate. For Goldmann applanation, these anesthetics must be combined with a fluorescein dye.

Both proparacaine and benoxinate are esters of para-aminobenzoic acid (PABA) that are used for topical ophthalmic anesthesia. Both have onset of action in approximately 10-20 seconds and both duration of action of 10-20 minutes. They provide sufficient anesthesia to permit minor procedures involving the superficial cornea and conjunctiva. Proparacaine is commonly used alone, but can be purchased pre-mixed with fluorescein dye, whereas, benoxinate is only available in combination with fluorescein dye1. Fluorescein sodium is a yellow acid dye from the xanthenes family that absorbs light of the 493 nanometer wavelength (blue) and then emits or fluoresces light of 520 nanometer wavelength (yellow-green). This dye is ubiquitous in ophthalmologic practices as it is used both intravenously and topically to assist in making ophthalmologic diagnoses1.

For contact tonometry, one of these topical anesthetics is traditionally instilled in each eye and the intraocular pressure is then measured. This is typically done by a technician first, and if there is any question regarding the measurement it is repeated again by the physician seeing the patient. In academic institutions the intraocular pressure may also be routinely checked additional times by the resident. For certain patients suspected of having glaucoma the intraocular pressure variation throughout the day is monitored in what is called a diurnal curve measurement. With this test, the intraocular pressure may be checked upwards of ten (10) times in a single day (each measurement with an additional instillation of topical anesthetic). All of these examinations are done with minimal danger and with little discomfort for the patient.

Despite this standard protocol for measurement of the intraocular pressure, it has been suggested that the very anesthetic agents we use to measure the pressure may actually cause some lowering of the intraocular pressure. In rabbits proparacaine has recently been shown to reduce episcleral venous pressure, an important component of the intraocular pressure, and the intraocular pressure itself (Zamora). Attempts to show the pressure lowering effect of these frequently used topical anesthetics in humans using our traditional intraocular measurement devices has been difficult as all three methods mentioned above require topical anesthetic. Some European studies have used non-contact tonometry to verify these findings. For example, Montero et al used non-contact tonometry to determine the effect of the topical anesthetics and found that there was a statistically significant decrease in the intraocular pressure after application of topical anesthetic3. Baudouin et al also found that, when measured via non-contact tonometry, some topical anesthetics lower the intraocular pressure4. In their study the topical anesthetics, oxybuprocaine and betoxycaine used more frequently in the United States. Both of these studies were done using non-contact tonometry. Traditionally with non-contact tonometry, a puff of air is directed towards the corneal surface and the displacement of the corneal surface is measured and used to estimate the intraocular pressure. However, in the United States most ophthalmology offices rely on contact tonometry to evaluate the intraocular pressure rather than non-contact tonometry. Based on our review of the literature, no one has yet measured the intraocular pressure lowering effects of these topical anesthetics with contact tonometry.

There is a currently a device on the market which is approved by the Food and Drug Administration that is able to measure intraocular pressure via contact tonometry that does not require use of topical anesthetic drops. This device is sold as the ICare tonometer. The ICare is a tonometer that uses a rebound technology in which a very light-weight probe is used to make momentary contact with the cornea. In rebound technology, the motion parameters of the probe are recorded during the measurement. An induction based coil system and advanced algorithms analyze the probe deceleration, contact time and other parameters as the probe touches the cornea. The deceleration and rebound parameters change as a function of the intraocular pressure. The tonometer is preprogrammed for six measurements, discarding the highest and lowest intraocular pressure readings, and calculating the average pressure value. The pressure is recorded in millimeters of mercury (mmHg). No anesthesia is involved because the touch of the probe is so gentle that intraocular pressure measurement is barely noticed by the subject5. The ICare is currently used on patients in our clinic for whom the traditional intraocular pressure measurement devices have not been appropriate like newborns and infants. It does not require topical anesthesia and recent data supports that its intraocular pressure measurements are reliable6,7. Thus, the ICare tonometer finally provides a way to use contact tonometry to verify whether or not the two most commonly used topical anesthetics lower intraocular pressure.

02

Conditions studied

  • Normal Tension Glaucoma

Browse trials for

03

In context

Low Tension Glaucoma

60 studies on the registry are indexed under Low Tension Glaucoma; 11 are open to participants now.

This study's enrollment of 43 is below the median of 97 across 29 observational studies indexed under Low Tension Glaucoma.

Browse Low Tension Glaucoma studies →

Lead sponsor

University of Nebraska is the lead sponsor of 473 studies on the registry; 66 are open to participants now.

Of its 75 completed or terminated interventional studies of FDA-regulated products, 46 (61%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Subjects 19 years of age and older with normal eyes and with ocular disease.

Inclusion criteria

  • Subjects must be 19 years of age and older

Exclusion criteria

Exclusion Criteria:

  • Corneal diseases including corneal transplants, corneal dystrophies, or trauma to the cornea that may prevent reliable tonometry of either eye.
  • Intolerant to topical Proparacaine and Benoxinate
  • Pregnant or nursing
  • 18 years of age and younger.
  • Physical limitation preventing ability to obtain reliable intraocular measurements (e.g. difficulty positioning subjects in front of the slit lamp or inability to keep eyes open during the intraocular pressure checks).
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
43 participants (actual)
06

What researchers measure

Primary outcomes

  1. Measured pressures in subjects' eyes with and without anesthetics.

    Intraocular pressure is measured via Goldmann applanation tonometry, which is considered the standard method of measurement with and without anesthetics.

    Time frame: 30 minutes

07

Study locations

1 site
  • University of Nebraska Medical Center, Department of Ophthalmology
    Omaha, Nebraska 68198, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01254149
Lead sponsor
University of Nebraska
Responsible party
Sponsor
First posted
Dec 6, 2010
Start date
Jan 17, 2011
Primary completion
Apr 1, 2012
Completion
Apr 1, 2012
Last update
Sep 1, 2023

Study contacts

Nathan Welch, MD
principal investigator · UNMC Department of Ophthalmology and Visual Sciences

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion